ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Aureka Biotechnologies closed a new funding round. The company secured fresh capital to advance its biotechnology operations. Specific financial terms and participating investors were not disclosed in the announcement.
Tap to vote and see what everyone thinks.
Summary by ByteBrief